ARCHIVES

Fisher and Redmond Subject Of Misconduct Investigation; ORI

This article is from The Cancer Letter archive.

Vol. 20 No. 18 | May 6, 1994

Download PDF Visit The Full Archive

Related Articles

Zometa Prevents Bone Loss In Premenopausal Women

August 29, 2008

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

January 7, 2005

NCI Rethinks Cancer Center Grants

March 14, 2014

By Defending Potti, Duke Officials Become Target Of Charges Of Institutional Failure

July 23, 2010

Florida Creates State Cancer Control Program

August 10, 1979

Committee Approves NDA For Tamoxifen

January 21, 1977